These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 11109756)

  • 1. Exposer rate of hepatitis E (IgG) in a selected population of children and adults in Karachi.
    Qureshi H; Shahid A; Mujeeb SA
    J Pak Med Assoc; 2000 Oct; 50(10):352-4. PubMed ID: 11109756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-epidemiology of hepatitis E virus (HEV) in urban and rural children of North India.
    Mathur P; Arora NK; Panda SK; Kapoor SK; Jailkhani BL; Irshad M
    Indian Pediatr; 2001 May; 38(5):461-75. PubMed ID: 11359972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis E virus (HEV) antibody in pregnant women of Karachi.
    Shams R; Khero RB; Ahmed T; Hafiz A
    J Ayub Med Coll Abbottabad; 2001; 13(3):31-5. PubMed ID: 11873396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E virus infection in individuals at high risk of transmission of non-A, non-B hepatitis and sexually transmitted diseases.
    Psichogiou M; Tzala E; Boletis J; Zakopoulou N; Loutradi A; Maliori M; Kourea-Kremastinou J; Stratigos J; Hatzakis A
    Scand J Infect Dis; 1996; 28(5):443-5. PubMed ID: 8953670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of IgG antibodies to hepatitis E in urban and rural southern India.
    Vivek R; Chandy GM; Brown DW; Kang G
    Trans R Soc Trop Med Hyg; 2010 Apr; 104(4):307-8. PubMed ID: 19729178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H. pylori IgG antibodies in children.
    Qureshi H; Hafiz S; Medhi I
    J Pak Med Assoc; 1999 Jun; 49(6):143-4. PubMed ID: 10599195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antibodies to hepatitis A, B, C, and E viruses in a healthy population in Leon, Nicaragua.
    Perez OM; Morales W; Paniagua M; Strannegard O
    Am J Trop Med Hyg; 1996 Jul; 55(1):17-21. PubMed ID: 8702016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of hepatitis E virus infection in 2-25-year-olds in Sari district, Islamic Republic of Iran.
    Saffar MJ; Farhadi R; Ajami A; Khalilian AR; Babamahmodi F; Saffar H
    East Mediterr Health J; 2009; 15(1):136-42. PubMed ID: 19469436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hepatitis A and E virus infections among healthy children in Mongolia: evidence for infection with a subgenotype IA HAV in children.
    Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Okamoto H
    J Med Virol; 2007 Jan; 79(1):18-25. PubMed ID: 17133554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis E infection in children with liver transplantation.
    Halac U; Béland K; Lapierre P; Patey N; Ward P; Brassard J; Houde A; Alvarez F
    Gut; 2012 Apr; 61(4):597-603. PubMed ID: 22115826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study.
    Mohebbi SR; Rostami Nejad M; Tahaei SM; Pourhoseingholi MA; Habibi M; Azimzadeh P; Naghoosi H; Karayiannis P; Zali MR
    Trans R Soc Trop Med Hyg; 2012 Sep; 106(9):528-31. PubMed ID: 22835757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of sporadic hepatitis E in Ivory Coast based on still problematic serology].
    Rioche M; Dubreuil P; Kouassi-Samgare A; Akran V; Nordmann P; Pillot J
    Bull World Health Organ; 1997; 75(4):349-54. PubMed ID: 9377791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Initial results of monitoring hepatitis E virus antibodies in selected population groups in the West Bohemia Region. Preliminary report].
    Pazdiora P; Nĕmecek V; Topolcan O
    Epidemiol Mikrobiol Imunol; 1996 Sep; 45(3):117-8. PubMed ID: 8998603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan.
    Tanaka E; Matsumoto A; Takeda N; Li TC; Umemura T; Yoshizawa K; Miyakawa Y; Miyamura T; Kiyosawa K
    J Viral Hepat; 2005 Jul; 12(4):439-42. PubMed ID: 15985017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia.
    Bile K; Isse A; Mohamud O; Allebeck P; Nilsson L; Norder H; Mushahwar IK; Magnius LO
    Am J Trop Med Hyg; 1994 Oct; 51(4):466-74. PubMed ID: 7943574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis viruses infection situation in human population of the Gansu province].
    Lu J; Li HY; Tian RG; Jiang YZ; Xu YN; Yu DS; Jiang JX; Bi SL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):349-51. PubMed ID: 20387483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-wise exposure rates to hepatitis e virus in a southern Indian patient population without liver disease.
    Daniel HD; Warier A; Abraham P; Sridharan G
    Am J Trop Med Hyg; 2004 Nov; 71(5):675-8. PubMed ID: 15569803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis E virus antibodies in children in Germany.
    Krumbholz A; Neubert A; Joel S; Girschick H; Huppertz HI; Kaiser P; Liese J; Streng A; Niehues T; Peters J; Sauerbrey A; Schroten H; Tenenbaum T; Wirth S; Zell R; Sauerbrei A
    Pediatr Infect Dis J; 2014 Mar; 33(3):258-62. PubMed ID: 24168981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure rate of hepatitis A and E (IgG) in children.
    Qureshi H; Hafiz S
    J Pak Med Assoc; 2000 Aug; 50(8):284-5. PubMed ID: 10992719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.